GSK plc (ETR:GS71)

Market Cap	62.26B
Revenue (ttm)	37.94B
Net Income (ttm)	3.11B
Shares Out	n/a
EPS (ttm)	0.75
PE Ratio	19.99
Forward PE	n/a
Dividend	0.72 (4.68%)
Ex-Dividend Date	Feb 20, 2025

Volume	151,543
Average Volume	906,148
Open	15.65
Previous Close	15.44
Day's Range	15.60 - 15.94
52-Week Range	14.49 - 21.24
Beta	0.30
RSI	39.25
Earnings Date	Apr 30, 2025

About GSK plc

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, infectious, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, inflammation, and other specialty medicine product...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1715
• Employees: 68,629
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: GS71

Financial Performance

In 2024, GSK plc's revenue was 31.38 billion, an increase of 3.46% compared to the previous year's 30.33 billion. Earnings were 2.58 billion, a decrease of -47.75%.

Financial numbers in GBP